Conference Committee

Priya started her career in Clinical Data Management around end of 2008 and has held a variety of positions at pharmaceutical companies, CROs and Pharma BPO&Consulting, with increasing responsibility that expands to SDTM & Clinical Data Analytics. In the recent past, she led an initiative to develop strategies for future roles in Clinical Data Sciences. She is associated with various volunteer organizations like CDISC and Pinnacle21 wherein she is actively involved in creating clinical data standards and ensuring that submission data is compliant to regulatory agencies. In early 2024, she received “Certificate of Specialization in Strategy” from Harvard Business School Online, empowering her areas of specialties in developing strategies to ensure smooth execution of end-to-end Clinical Data Management activities, create Data Driven Decision Metrics for surveillance activities, reducing cycle times , improve process efficiencies and many more.

She is an active Conference Committee member, “Data Sciences” DMEG, conducts hot topic discussions at ACDM, authored articles at SCDM, presented about various CDM topics at various conferences, and published webinars.

James serves as DCT Platform Consultant within Medidata’s Advisory Services team. He started his career in clinical research 10 years ago and has broad experience covering academic, CRO, vendor and sponsor organizations. Whilst working for a sponsor he led the implementation of new EDC and eCOA technologies; a project which earned second-place in ‘Innovation in Data Management’ at the ACDM awards in 2020.

James recently completed a Master of Science in Clinical Trials to further his understanding of the full landscape and has previously presented at ACDMi. His key interests include eCOA, emerging technologies and DCTs.

Stephanie started her career in clinical data management over 19 years ago on the Contract Research Organization (CRO) side of the industry. She has since then held various positions with increasing responsibility at CROs, pharmaceutical and in both large and small biotechnology companies.

Stephanie has a comprehensive knowledge of data management in clinical research from working on various clinical studies from study set up through to regulatory submissions. Stephanie has extensive experience in vendor oversight, working with FSP models and managing outsourced data management teams. She has experience in a wide range therapeutic areas including oncology, infectious diseases, immunology, neuroscience and rare diseases within data management.

Stephanie has been a member of the ACDM for many years and joined the conference committee in 2020.

Ali works within the Clinical Operations team at Vitaflo International Ltd as Clinical Data Manager and is responsible for all aspects of data management for the Vitaflo clinical trial portfolio. She works cross functionally with internal and external study stakeholders to ensure that data management procedures and deliverables are met and performed in accordance with Good Clinical Practice (GCP) and current regulatory and ethical requirements.

Ali has a wealth of clinical research experience having begun her data management career in 1996 and has previously worked in various data management roles in the pharmaceutical industry, academia, NHS and more recently for a specialised data management and biometrics Contract Research Organsiation (CRO).

Ali has been involved in the ACDM for many years, initially as a newsletter committee member, then Newsletter Editor and Chair.  Ali joined the conference committee in 2009, and apart from a short break, has been involved since.

A highly skilled leader with extensive Clinical Data Systems and Data Management experience from working in a large and mid-sized Contract Research Organisations, Pharmaceutical company, and academic Clinical Trials Unit. Decisive and proficient in leadership and management, including building, coaching, and motivating teams; with a professional and calm approach in times of pressure. Extensive project management of large multi-national and small studies, across a wide range of therapeutic areas and clinical phases; demonstrating good internal and international collaborative approaches whilst adhering to ICH and GCP Guidelines. 

Experience of introduction of new systems and systems migration with stakeholders nationally and globally, with consideration for Business Continuity, Information governance, IT Security, Audit and Quality management.

Former Chair of the UK CRC Information Systems Operational Group.

Jas has over 25 years in the life sciences and clinical technologies – particularly within clinical systems, linked to data collection and management. Having started his career as a data manager when clinical trials were predominantly done on paper, Jas has seen the industry evolve and develop over the years and gained a deep understanding and experience of working with most eClinical / CDMS solutions used in the industry and end to end clinical trial processes. Currently, Jas follows keenly the influence of omics data and its impact on clinical trials of the future and precision medicine.

Lynette started her career in Clinical Data Management more than 19 years ago, as a Clinical Data Coordinator at a CRO. She’s held positions of increasing responsibility at different CROs within the Clinical Data Management setting as well as a few years within Project Management. In 2019 she moved to the Pharma side and is now part of the Clinical Data Operations leadership team, helping to define strategic direction for the department and working on several process initiatives.

Lynette recently joined the ACDM Conference Committee and looks forward to being part of many more successful conferences in the future.

Sandy has over 20 years of experience in Data Management and is currently employed at GSK as a DM Director for HIV the HIV portfolio. Sandy leads teams across phase I to IV studies across a number of assets, with a passion for delivering excellence and ensuring teams work well cross-functionally and bring quality and efficiency to our standards and deliverables. More recently she has been involved in using AIML tools and its potential within DM.